Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine followed by adjuvant chemotherapy in patients with malignant pleural mesothelioma

Journal of Thoracic Oncology

Volumn 6, Issue 10, 2011, Pages 1746-1752

  Lang Lazdunski, Loïc ^a,b   Bille, Andrea ^a,b   Belcher, Elizabeth ^a,b   Cane, Paul ^a,b   Landau, David ^a,b   Steele, Jeremy ^a,b   Taylor, Henry ^a,b   Spicer, James ^a,b  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

chemotherapy; Hyperthermic pleural lavage; Malignant pleura mesothelioma; Pleurectomy decortication; Surgery

Indexed keywords

POVIDONE IODINE;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHYLOTHORAX; DECORTICATION; HUMAN; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALIGNANT MESOTHELIOMA; MULTIMODALITY CANCER THERAPY; OBSERVATIONAL STUDY; OVERALL SURVIVAL; PLEURA MESOTHELIOMA; PLEURECTOMY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 80052964099     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3182288af9     Document Type: Article

References (30)

1. Peto J, Decarli A, La Vecchia C, et al. The European mesothelioma epidemic. Br J Cancer 1999;79:666-672. (Pubitemid 29046253)
2. Muers MF, Stevens RJ, Fisher P, et al. Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial. Lancet 2008;371: 1685-1694. (Pubitemid 351671885)
3. Vogelzang NJ, Rusthoven JJ, Symanowski J, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 2003;21: 2636-2644. (Pubitemid 46606305)
4. Maziak DE, Gagliardi A, Haynes AE, et al. Surgical management of malignant pleural mesothelioma: a systematic review and evidence summary. Lung Cancer 2005;48:157-169.
5. Sugarbaker DJ, Flores RM, Jacklitsch M, et al. Resection margins, extrapleural nodal status and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 1999;117:54-63.
6. Rusch VW, Piantadosi S, Holmes EC. The role of extrapleural pneumonectomy in malignant pleural mesothelioma. A Lung Cancer Study Group trial. J Thorac Cardiovasc Surg 1991;102:1-9.
7. Krug LM, Pass HI, Rusch VW, et al. Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma. J Clin Oncol 2009;27:3007-3013.
8. Weder W, Stahel RA, Bernhard J, et al. Multicenter trial of neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. Ann Oncol 2007;18:1196-1202. (Pubitemid 47244366)
9. De Perrot M, Feld R, Cho BC, et al. Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Clin Oncol 2009;27:1413-1418.
10. Treasure T, Waller D, Tan C, et al. The mesothelioma and radical surgery randomized controlled trial: the MARS feasibility study. J Thorac Oncol 2009;10:1254-1258.
11. Sugarbaker DJ, Jaklitsch MT, Bueno R, et al. Prevention, early detection and management of complications after 328 consecutive extrapleural pneumonectomies. J Thorac Cardiovasc Surg 2004;128:138-146. (Pubitemid 38881208)
12. Allen AM, Czerminska M, Janne P, et al. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. Int J Radiat Oncol Biol Phys 2006;65:640-645. (Pubitemid 43795851)
13. Janne PA, Baldini EH. Patterns of failure following surgical resection for malignant pleural mesothelioma. Thorac Surg Clin 2004;14:567-573. (Pubitemid 39314491)
14. Wanebo HJ, Martini N, Melamed MR, et al. Pleural mesothelioma. Cancer 1976;38:2481-2488. (Pubitemid 8015884)
15. Neragi-Miandoab S, Richards WG, Sugarbaker DJ. Morbidity, mortality, mean survival and the impact of histology on survival after pleurectomy in 64 patients with malignant pleural mesothelioma. Int J Surg 2008;6:293-297.
16. Lee TT, Everett DL, Shu HK, et al. Radical pleurectomy/decortication and intraoperative radiotherapy followed by conformal radiation with or without chemotherapy for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2002;124:1183-1189. (Pubitemid 35417006)
17. Boutin C, Rey F, Viallat JR. Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. Chest 1995;108:754-758.
18. Butchart EG, Ashcroft T, Barnsley WC, et al. Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients. Thorax 1976;31:15-24.
19. Pilling JE, Nicholson AG, Harmer C, et al. Prolonged survival due to spontaneous regression and surgical excision of malignant mesothelioma. Ann Thorac Surg 2007;83:314-315. (Pubitemid 44917861)
20. Tilleman TR, Richards WG, Zellos L, et al. Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study. J Thorac Cardiovasc Surg 2009;138:405-411.
21. McCormack PM, Nagasaki F, Hilaris BS, et al. Surgical treatment of pleural mesothelioma. J Thorac Cardiovasc Surg 1982;84:834-842. (Pubitemid 13099539)
22. Rusch V, Saltz L, Venkatraman E, et al. A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma. J Clin Oncol 1994;12:1156-1163. (Pubitemid 24173928)
23. Richards WG, Zellos L, Bueno R, et al. Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma. J Clin Oncol 2006;24:1561-1567. (Pubitemid 46638779)
24. GuptaV, Mychalczak B, Krug L, et al. Hemithoracic radiation after pleurectomy/decortication for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 2005;63:1045-1052. (Pubitemid 41505282)
25. Broomfield S, Currie A, Van der Most RG, et al. Partial, but not complete, tumor-debulking surgery promotes protective antitumor memory when combined with chemotherapy and adjuvant immunotherapy. Cancer Res 2005;65:7580-7584. (Pubitemid 41297228)
26. Lee SW, Gleason NR, Bessler M, et al. Peritoneal irrigation with povidone-iodine solution after laparoscopic-assisted splenectomy significantly decreases port-tumor recurrence in a murine model. Dis Colon Rectum 1999;42:319-326. (Pubitemid 29143829)
27. Opitz I, Sigrist B, Hillinger S, et al. Taurolidine and povidone-iodine induce different types of cell death in malignant pleural mesothelioma. Lung Cancer 2007;56:327-336. (Pubitemid 46679090)
28. Sugarbaker PH, Yan TD, Stuart OA, et al. Comprehensive management of diffuse malignant peritoneal mesothelioma. Eur J Surg Oncol 2006; 32:686-691. (Pubitemid 44063999)
29. Van Ruth S, Baas P, Haas RL, et al. Cytoreductive surgery combined with intraoperative hyperthermic intrathoracic chemotherapy for stage I malignant pleural mesothelioma. Ann Surg Oncol 2003;10:176-182. (Pubitemid 40485939)
30. Wagenfeld L, Zeitz O, Richard G. Visual loss after povidone-iodine pleurodesis. N Engl J Med 2007;357:1264-1265.